Biodexa Pharmaceuticals PLC Sustainability Reports

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on the development of innovative products for the treatment of rare diseases, including gastrointestinal and brain cancers.

Sector: Manufacturing

Country: United Kingdom

Exchange: Nasdaq

LEI: 549300GKR2G40H3QFY57

4 reports from 2022 to 2025

• Biodexa Pharmaceuticals PLC 2025 Code of Business Conduct and Ethics
• Biodexa Pharmaceuticals PLC 2025 Annual Report
• Biodexa Pharmaceuticals PLC 2024 Annual Report
• Biodexa Pharmaceuticals PLC 2022 Annual Report